|
Diabetes, Vol 49, Issue 5 688-692, Copyright © 2000 by American Diabetes Association
Secretion of tumor necrosis factor-alpha shows a strong relationship to insulin-stimulated glucose transport in human adipose tissue
P Lofgren, V van Harmelen, S Reynisdottir, E Naslund, M Ryden, S Rossner and P Arner
Karolinska Institute, Clinical Research Center, and the Department of Medicine, Huddinge University Hospital, Stockholm, Sweden.
Some animal models suggest that tumor necrosis factor (TNF)-alpha is a key
component in obesity-linked insulin resistance because it inhibits insulin
receptor signaling and glucose transport in insulin-sensitive tissues.
However, in vivo data in humans have given conflicting results regarding
the relationship between circulating TNF-alpha levels and insulin
sensitivity. In the present study, the potential local role of TNF-alpha on
insulin action in human subcutaneous adipose tissue was studied in 42 obese
women (BMI 39+/-10 kg/m2). We found a strong inverse correlation between
adipose TNF-alpha secretion and maximum insulin-stimulated glucose
transport in adipocytes that was independent of fat cell volume, age, and
BMI (P < 0.001, r = 0.58). As much as one-third of the variation in
insulin-stimulated glucose transport could be accounted for by variations
in TNF-alpha secretion. There was no significant correlation (r = 0.11)
between secretion of adipose plasminogen activator inhibitor 1 and glucose
transport. Furthermore, subcutaneous adipose tissue of 4 obese women (BMI
40+/-4) incubated with TNF-A for 24 h showed a one-third
concentration-dependent inhibition of insulin-stimulated glucose transport
(P < 0.01). In conclusion, adipose TNF-alpha may be an important
specific and local factor in adipose tissue that influences the ability of
insulin to stimulate glucose transport in human fat cells, at least in
obese women.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. G. Gosman, H. I. Katcher, and R. S. Legro
Obesity and the role of gut and adipose hormones in female reproduction
Hum. Reprod. Update,
September 1, 2006;
12(5):
585 - 601.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Gibson and P. Froguel
Genetics of the APM1 Locus and Its Contribution to Type 2 Diabetes Susceptibility in French Caucasians
Diabetes,
November 1, 2004;
53(11):
2977 - 2983.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kudo, A. Sugawara, A. Uruno, K. Takeuchi, and S. Ito
Transcription Suppression of Peroxisome Proliferator-Activated Receptor {gamma}2 Gene Expression by Tumor Necrosis Factor {alpha} via an Inhibition of CCAAT/ Enhancer-binding Protein {delta} during the Early Stage of Adipocyte Differentiation
Endocrinology,
November 1, 2004;
145(11):
4948 - 4956.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Arvidsson, N. Viguerie, I. Andersson, C. Verdich, D. Langin, and P. Arner
Effects of Different Hypocaloric Diets on Protein Secretion From Adipose Tissue of Obese Women
Diabetes,
August 1, 2004;
53(8):
1966 - 1971.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. K Heilbronn and E. Ravussin
Calorie restriction and aging: review of the literature and implications for studies in humans
Am. J. Clinical Nutrition,
September 1, 2003;
78(3):
361 - 369.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Krakoff, T. Funahashi, C. D.A. Stehouwer, C. G. Schalkwijk, S. Tanaka, Y. Matsuzawa, S. Kobes, P. A. Tataranni, R. L. Hanson, W. C. Knowler, et al.
Inflammatory Markers, Adiponectin, and Risk of Type 2 Diabetes in the Pima Indian
Diabetes Care,
June 1, 2003;
26(6):
1745 - 1751.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Thorand, H. Lowel, A. Schneider, H. Kolb, C. Meisinger, M. Frohlich, and W. Koenig
C-Reactive Protein as a Predictor for Incident Diabetes Mellitus Among Middle-aged Men: Results From the MONICA Augsburg Cohort Study, 1984-1998
Arch Intern Med,
January 13, 2003;
163(1):
93 - 99.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Xu, K. T. Uysal, J. D. Becherer, P. Arner, and G. S. Hotamisligil
Altered Tumor Necrosis Factor-{alpha} (TNF-{alpha}) Processing in Adipocytes and Increased Expression of Transmembrane TNF-{alpha} in Obesity
Diabetes,
June 1, 2002;
51(6):
1876 - 1883.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-P. Bastard, M. Maachi, J. T. van Nhieu, C. Jardel, E. Bruckert, A. Grimaldi, J.-J. Robert, J. Capeau, and B. Hainque
Adipose Tissue IL-6 Content Correlates with Resistance to Insulin Activation of Glucose Uptake both in Vivo and in Vitro
J. Clin. Endocrinol. Metab.,
May 1, 2002;
87(5):
2084 - 2089.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Xu, J. Hirosumi, K. T. Uysal, A. D. Guler, and G. S. Hotamisligil
Exclusive Action of Transmembrane TNF{alpha} in Adipose Tissue Leads to Reduced Adipose Mass and Local But Not Systemic Insulin Resistance
Endocrinology,
April 1, 2002;
143(4):
1502 - 1511.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Kirwan, R. K. Krishnan, J. A. Weaver, L. F. Del Aguila, and W. J. Evans
Human aging is associated with altered TNF-alpha production during hyperglycemia and hyperinsulinemia
Am J Physiol Endocrinol Metab,
December 1, 2001;
281(6):
E1137 - E1143.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Teruel, R. Hernandez, and M. Lorenzo
Ceramide Mediates Insulin Resistance by Tumor Necrosis Factor-{alpha} in Brown Adipocytes by Maintaining Akt in an Inactive Dephosphorylated State
Diabetes,
November 1, 2001;
50(11):
2563 - 2571.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. Kern, S. Ranganathan, C. Li, L. Wood, and G. Ranganathan
Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance
Am J Physiol Endocrinol Metab,
May 1, 2001;
280(5):
E745 - E751.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Diabetes Association.
|
|
| |
|